Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction

Keyphrases

• Autoimmune Disease 100%
• Therapeutic Use 100%
• Immunosuppression 100%
• Tolerance Induction 100%
• Nanomedicine 100%
• Type 1 Diabetes Mellitus (T1DM) 40%
• Rheumatoid Arthritis 40%
• Multiple Sclerosis 40%
• Type I Diabetes 40%
• Immunosuppressive Agents 40%
• Psoriasis 40%
• Scleroderma 40%
• Systemic Lupus Erythematous 40%
• Autoimmune Disease Treatment 40%
• Delivery Strategy 40%
• Pathologic 20%
• Therapeutic Agents 20%
• Immune Response 20%
• Immunosuppressive Therapy 20%
• Biological Therapy 20%
• Nanotechnology 20%
• Patient Compliance 20%
• Functional Disability 20%
• Promising Strategies 20%
• Systemic Side Effects 20%
• Multiple Organ Failure 20%
• Route of Administration 20%
• Clinical Potential 20%
• Immunological Tolerance 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Autoimmune Disease 100%
• Nanomedicine 100%
• Rheumatoid Arthritis 28%
• Multiple Sclerosis 28%
• Systemic Lupus Erythematosus 28%
• Insulin Dependent Diabetes Mellitus 28%
• Psoriasis 28%
• Scleroderma 28%
• Disease 14%
• Adverse Event 14%
• Biological Product 14%
• Combination Therapy 14%
• Immunosuppressive Agent 14%
• Multiple Organ Failure 14%
• Route of Administration 14%

Immunology and Microbiology

• Autoimmune Disease 100%
• Immunosuppression 100%
• Inflammatory Arthritis 28%
• Systemic Lupus Erythematosus 28%
• Multiple Sclerosis 28%
• Scleroderma 28%
• Immune Response 14%
• Immune Tolerance 14%
• Biological Product 14%
• Immunosuppressive Drug 14%